Home  |  Speakers  |  Agenda  |  Venue  |  Delegates  |  Sponsors  |  Media  |  Register








Recent advancements in the biomarker, CDx genomic and big data space have meant that some of the fundamental challenges of precision medicine are being realised.  The potential for personalized medicine and therefore the possibility of delivering superior outcomes for patients is in reach.  There is, however, a lot more to do.  Alongside the continued developments in science as well as improvements in clinical trial design, support mechanisms such as market access /reimbursement/ regulatory strategies need to be further developed.  Continued work by all stakeholders is therefore vital for success.

The congress was designed for a variety of stakeholders from drug and DX developers, payers, healthcare providers, academics to technology solution providers and will bring together a community of experts working in all areas of precision and personalised medicine such as biomarkers, CDx, translational medicine, clinical trials, genomics, NGS, bioinformatics and health economics. 

The meeting provides the opportunity to take home cutting edge strategies, case study examples and methods to allow you to both implement and take the vital next steps in delivering precision medicine.  This will be achieved through a vibrant exhibition room full of technology providers showcasing their technologies and other solutions, expert led case study presentations and interactive Q&A panel discussions examining topics during four separate tracks covering the areas below.

Day One, Stream One – Strategies & Technologies to Enable Successful Implementation of Precision Medicine
Day One, Stream Two – Precision Medicine Therapeutic Case Studies
Day Two, Stream One – Biomarker & Companion Diagnostics Development to Deliver Precision Medicine
Day Two, Stream Two – Integrating Personal Genomics, Big Data and Bioinformatics

For a detailed synopsis, please visit the agenda page.


Keynote Speakers

Lon CardonLon Cardon
GSK
Ruth MarchRuth March
AstraZeneca
Eric LaiEric Lai
Takeda


Munir PirmohamedProf Sir Munir Pirmohamed
Wolfson Centre for Personalised
                  Medicine


The 3rd Precision Medicine Congress is part of our successful Drug Discovery series which includes innovative meetings on the Human Microbiome, Synthetic Biology, qPCR / dPCR, Digital Pathology & Biologics among others.    www.globalengage.co.uk/events/

As you can hear from the short video review below, this focused and insightful meeting which attracted over 175 attendees last year has been praised for its stimulating, interactive and engaging environment where it has brought together a multi-disciplined community that can learn and engage from one another in order to create an environment which can develop better medicines for the patient.



Supported by:
    


Munir PirmohamedProfessor Sir Munir Pirmohamed
The Wolfson Centre for Personalised Medicine
The University of Liverpool


I am delighted to be making a keynote presentation at the 3rd Precision Medicine Congress in London this September.

Precision Medicine is at an exciting time of development because not only do we have a much greater understanding of the architecture of the genome, but we are beginning to translate our discoveries into a specific treatment for a particular patient.

Although we are now better able to stratify disease and target specific drugs to treat particulars disease phenotypes, there is still variability in how the drug is handled by the body and in the way it interacts with a target cell. By trying to understand the individual variability in drug response, it becomes possible to evaluate the mechanisms and develop strategies that will personalise healthcare – strategies that will have to accommodate complicating environmental factors such as patient’s dietary and drinking habits, whether they smoke or are also taking different medicines.

I look forward to discussing these themes in my presentation on Pharmacogenomics and its role in precision medicine at the meeting as well as learning about the advances in omics technologies and computational developments that are driving forward the advent of personalised medicine.



To receive  updates and get special offers before anyone else, please complete the form below.








Newsletter


Register
                  Now

Sponsors

Platinum






Gold







Silver


Other













See all























Register
                    Now


For further information please contact;

Steve Hambrook

Conference Director

steve@globalengage.co.uk



About Global Engage  |  T&Cs  |  Agenda  |  Testimonials  |  Register



Copyright:  Global Engage Ltd.   Registered in England.  No: 6950636